Autor/in Harter, P Mahner, S du Bois, A 4 Hilpert, F 3 Wagner, U 2 Heitz, F 1 König, K 1 Lindel, K 1 Meier, W 1 Mustea, A 1 Ortmann, O 1 Ortner, P 1 Petru, E 1 Pfisterer, J 1 Pujade-Lauraine, E 1 Ray-Coquard, I 1 Reuss, A 1 Reuß, A 1 Runnebaum, I 1 Sehouli, J 1 Staehle, A 1 Wegscheider, K 1 zu Eulenburg, Christine 1 alle zeigenListe einklappen
Surgical intervention in relapsed ovarian cancer is beneficial: pro Harter, P Heitz, F Mahner, S Hilpert, F du Bois, A 2013 - Forschungsinformationssystem des UKE
Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer Harter, P Mahner, S Hilpert, F Runnebaum, I Ortmann, O Mustea, A Sehouli, J 2013 - Forschungsinformationssystem des UKE
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013 Wagner, U Harter, P Hilpert, F Mahner, S Reuß, A du Bois, A Petru, E 2013 - Forschungsinformationssystem des UKE
Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials. Mahner, S zu Eulenburg, Christine Staehle, A Wegscheider, K Reuss, A Pujade-Lauraine, E Harter, P 2013 - Forschungsinformationssystem des UKE